Annual Drug Patent Expirations for DROSPIRENONE
Drospirenone is a drug marketed by Exeltis Usa Inc, Barr, Glenmark Pharms Ltd, Hetero Labs, Hlthcare, Jubilant Cadista, Mylan Labs Ltd, Watson Labs, Apotex, Dr Reddys Labs Sa, Lupin Ltd, Naari Pte Ltd, and Watson Labs Inc and, and is included in twenty NDAs. There are thirteen patents protecting this drug.
Drug patent litigation for DROSPIRENONE.
This drug has fifty-five patent family members in twenty-nine countries.
The generic ingredient in DROSPIRENONE is drospirenone; ethinyl estradiol; levomefolate calcium. There is one tentative approval for this compound. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
